Life Science News

RSS

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Company aims to democratise access to affordable biomedical research especially in cancer research and new drug development through its novel 3D cell culture platform

From Inventia Life Science 16 Aug 2022

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Inventia Life Science announced that its RASTRUM™ 3D cell culture platform has won the ANSTO Eureka Prize for Innovative Use of Technology at the 2021 Australian Museum Eureka Prizes.

From Inventia Life Science 16 Aug 2022

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science and Xylyx Bio today announced their strategic partnership following promising results developing more realistic, scalable, and reproducible 3D cell cultures for drug discovery and biomedical research.

From Inventia Life Science 16 Aug 2022

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

As a result of this partnership, Inventia Life Science will now offer BioLamina’s extensive range of Biolaminin® products incorporated into the pre-validated library of RASTRUM™ Matrices, recapitulating the key motifs found in the native tissue of various cell types.

From Inventia Life Science 16 Aug 2022

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ has taken out the top prize in the Experimental category. RASTRUM™ prints human cells into living tissue models to supercharge research into cancer and other diseases using revolutionary drop-on-demand technology.

From Inventia Life Science 16 Aug 2022

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science, a leader in automated generation of complex 3D cell models, and PhenoVista Biosciences, a top provider of custom imaging-based phenotypic assay services, have entered into a partnership to deliver high-content cell-based assay services for drug discovery.

From Inventia Life Science 16 Aug 2022

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform.

From Evonetix 16 Aug 2022

Researchers face challenges with stem cell lines that carry major DNA damage

Stem cells are a type of cell that can be configured to transform into almost any sort of cell in the body. They are presently used in research on organ development as well as in the initial phases of embryo development.

15 Aug 2022

Researchers determine a novel antiviral technique to combat bacteria

Bacteria use a wide range of defense strategies to combat viral infection, and some of these systems have resulted in game-changing technologies like CRISPR-based gene editing.

From Massachusetts Institute of Technology (MIT) 15 Aug 2022

Parents transmit genetic and epigenetic information to their offspring

The knowledge of what can be inherited from parents and how their life experiences impact children could be completely rewritten if a fundamental finding concerning a factor driving healthy development in embryos were made.

From Walter and Eliza Hall Institute of Medical Research (WEHI) 15 Aug 2022

Researchers modify the root structure of plants with synthetic genes

Crops need to be more adaptable than ever as extreme weather events like floods, droughts, and heat waves grow more frequently.

15 Aug 2022

Mount Sinai and Regeneron Genetics Center launch a large-scale genome sequencing project

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

12 Aug 2022

Circadian clock impacts cell growth, metabolism, and tumor development

Scientists from the University of California, Irvine, have defined how the circadian clock impacts cell growth, metabolism, and tumor progression in a new study.

12 Aug 2022

Fabimycin likely to be an effective treatment for drug-resistant bacteria

Bacteria that cause urinary tract infections are getting more and more resistant to many medications, and they are becoming more and more difficult to cure.

12 Aug 2022

Genetic mapping helps to analyze how cancer cells grow

Acknowledging which cells lend credence to which regions of cancer can help us better understand how a tumor has expanded and developed over time, such as how it has altered genetically.

12 Aug 2022

Biotrophic fungus uses host auxin signaling pathway for its own purposes

Ustilago maydis attacks and reproduces in the aerial parts of the corn plant. At the location of the infection, massive tumor-like tissue growths frequently develop. The size of these galls can exceed that of a child’s skull.

12 Aug 2022

Self‑pollinating flowering plant quickly loses genetic variation without bumble bees

Without bumble bees, a flowering plant that can self-pollinate lost substantial genetic variation within only nine generations, an experimental study found.

11 Aug 2022

Interseeded cover crops provide nitrogen services in organic corn systems

Fields of amber grain may be the poetic image of American farmland. And it's true that the U.S. grows plenty of wheat. But fields of yellow grain – corn – may be more accurate.

11 Aug 2022

Researchers discover antibiotic resistance genes in M. tuberculosis

More than 10,000 different Mycobacterium tuberculosis bacteria isolated from 23 different countries were subjected to a thorough investigation, which uncovered new genes linked to resistance to 13 first- and second-line novel and repurposed medicines.

11 Aug 2022

Study provides guidelines on how to design safer CRISPR reagents

The 2020 Nobel Prize in Chemistry was awarded to Jennifer A. Doudna and Emmanuelle Charpentier for developing the widely utilized and incredibly precise genome editing method known as CRISPR/Cas9

11 Aug 2022

Life Science News

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

Researchers face challenges with stem cell lines that carry major DNA damage

Researchers determine a novel antiviral technique to combat bacteria

Parents transmit genetic and epigenetic information to their offspring

Researchers modify the root structure of plants with synthetic genes

Mount Sinai and Regeneron Genetics Center launch a large-scale genome sequencing project

Circadian clock impacts cell growth, metabolism, and tumor development

Fabimycin likely to be an effective treatment for drug-resistant bacteria

Genetic mapping helps to analyze how cancer cells grow

Biotrophic fungus uses host auxin signaling pathway for its own purposes

Self‑pollinating flowering plant quickly loses genetic variation without bumble bees

Interseeded cover crops provide nitrogen services in organic corn systems

Researchers discover antibiotic resistance genes in M. tuberculosis

Study provides guidelines on how to design safer CRISPR reagents

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics